Dr. Priya Rastogi
Overview
Priya Rastogi, MD, is currently Associate Professor of Medicine at the University of Pittsburgh School of Medicine.Dr. Rastogi received a Bachelor of Arts degree in Chemistry from Miami University at Oxford, Ohio. She earned her MD at Wright State University School of Medicine in Dayton, Ohio and completed her residency in Internal Medicine at Saint Joseph's Hospital in Denver, Colorado, where she received the Resident of the Year Award. Her Fellowship was completed at the University of Pittsburgh School of Medicine in Pittsburgh, PA. During her fellowship, Dr. Rastogi's research was focused on Herceptin-induced cardiotoxicity, and she was awarded a grant from the National Surgical Breast and Bowel Project.Dr. Rastogi is board certified in Internal Medicine and Medical Oncology by the American Board of Internal Medicine. She is an associate member of the American Society of Clinical Oncology and the American Association for Cancer Research. She has several abstracts and research articles in leading journals, including Seminars in Breast Disease, Oncology, and Diseases of the Breast. Dr. Rastogi practices in the Womens Cancer Center at Magee-Womens Hospital will see over 125 new breast cancer consultations and over 1250 patient visits in 2004.Dr. Rastogi has participated in the Introduction to Being a Physician course for first year medical students at the University of Pittsburgh School of Medicine for two years and is also active within the community for lectures and presentations.
Dr. Rastogi is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Febrile Neutropenia, and Inflammatory Breast Cancer.
Dr. Rastogi is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 86 peer reviewed articles. Dr. Rastogi is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Halket Street, Suite 4628, Pittsburgh, PA 15213
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 42 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery. Dr. Burgess is board certified in American Board Of Internal Medicine. Dr. Burgess is currently accepting new patients.
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy. Dr. Brufsky is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brufsky is currently accepting new patients.
UPMC Hillman Cancer Center
Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Villaruz is board certified in American Board Of Internal Medicine. Dr. Villaruz is currently accepting new patients.
Frequently Asked Questions about Dr. Priya Rastogi
How do I make an appointment with Dr. Priya Rastogi?
You can book an appointment with Dr. Priya Rastogi by calling their office at 412-530-1161. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Priya Rastogi a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Priya Rastogi is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Priya Rastogi specialize in?
While Dr. Priya Rastogi is a Hematology Oncology, they have specific expertise in Breast Cancer, Triple-Negative Breast Cancer, and Febrile Neutropenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Priya Rastogi participate in research or clinical trials?
Yes. Dr. Priya Rastogi has published 86 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Priya Rastogi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Priya Rastogi accept my insurance?
Dr. Priya Rastogi accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 412-530-1161 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Rastogi isElite. Learn about Breast Cancer.
- Distinguished
- Triple-Negative Breast CancerDr. Rastogi isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- AngiosarcomaDr. Rastogi isAdvanced. Learn about Angiosarcoma.
- Febrile NeutropeniaDr. Rastogi isAdvanced. Learn about Febrile Neutropenia.
- HER2 Negative Breast CancerDr. Rastogi isAdvanced. Learn about HER2 Negative Breast Cancer.
- Inflammatory Breast CancerDr. Rastogi isAdvanced. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Rastogi isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- AgranulocytosisDr. Rastogi isExperienced. Learn about Agranulocytosis.
- MenopauseDr. Rastogi isExperienced. Learn about Menopause.
- PIK3CA-Related Overgrowth SpectrumDr. Rastogi isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.